1. Home
  2. CLGN vs SLAI Comparison

CLGN vs SLAI Comparison

Compare CLGN & SLAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CollPlant Biotechnologies Ltd

CLGN

CollPlant Biotechnologies Ltd

HOLD

Current Price

$0.43

Market Cap

18.4M

Sector

Health Care

ML Signal

HOLD

SLAI

SOLAI Limited American Depositary Shares (each representing one hundred (100) Class A Ordinary Shares)

N/A

Current Price

$0.86

Market Cap

15.5M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
CLGN
SLAI
Founded
2004
2001
Country
Israel
United States
Employees
N/A
N/A
Industry
Industrial Specialties
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
18.4M
15.5M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
CLGN
SLAI
Price
$0.43
$0.86
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$11.00
N/A
AVG Volume (30 Days)
149.1K
129.8K
Earning Date
05-27-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$240.45
$8.65
Revenue Next Year
$38.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$0.63
52 Week High
$4.98
$2.55

Technical Indicators

Market Signals
Indicator
CLGN
SLAI
Relative Strength Index (RSI) 48.11 54.26
Support Level $0.27 $0.81
Resistance Level $0.46 $0.98
Average True Range (ATR) 0.06 0.08
MACD 0.02 0.00
Stochastic Oscillator 83.59 62.19

Price Performance

Historical Comparison
CLGN
SLAI

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

About SLAI SOLAI Limited American Depositary Shares (each representing one hundred (100) Class A Ordinary Shares)

SOLAI Ltd is a technology-driven cryptocurrency infrastructure company. It is expanding from its foundation in crypto mining to build a blockchain-based ecosystem spanning AI, stablecoins, and payment infrastructure, and Solana treasury and staking operations supporting use cases across institutional settlement, commerce, consumer payments, and AI-native agent transactions. The group is leveraging its blockchain and data infrastructure expertise, aiming to enhance on-chain efficiency and expand participation across Solana and other blockchain ecosystems.

Share on Social Networks: